ClinicalTrials.gg
RecruitingNCT07676136Updated Nov 18, 2026

A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients

An interventional study of Gut directed hypnotherapy via telephone intervention and Educational recording in Disorders of Gut-brain Interaction, Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Inflammatory Bowel Diseases by Stanford University — 5 open to participants now, 5 under way, none of them phase 3. Inflammatory Bowel Diseases · Stanford University.

Started
2026
the only one that year
No phase
6 of 10
3 open now
Registered
10th of 10
by date

Among the 10 studies in Inflammatory Bowel Diseases by Stanford University, this one is the only one that started in 2026, is one of 6 with no phase, and was the 10th registered.

Inflammatory Bowel Diseases

1,555 studies on the registry are indexed under Inflammatory Bowel Diseases; 425 are open to participants now.

Browse Inflammatory Bowel Diseases studies →

Open to participants now

5 of the 10 studies in Inflammatory Bowel Diseases by Stanford University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 276 Inflammatory Bowel Diseases studies recruiting now, 134 (49%) set no upper age limit and 114 (41%) stop at 75 or younger; 75 take children under 18; 60 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Inflammatory Bowel Diseases by Stanford University, or all of them as a file.
02

Study summary

The purpose of the study is to compare the effectiveness of recorded gut-directed hypnosis to an educational recording in people with chronic problems in their gastrointestinal (GI) system. Patients who are hospitalized at Stanford Hospital for worsening pain and/or nausea will be considered for enrollment.

03

Conditions studied

  • Disorders of Gut-brain Interaction
  • Inflammatory Bowel Disease (IBD)
  • Irritable Bowel Syndrome
  • Abdominal Pain
  • Esophageal Disease

Keywords

  • hypnosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults admitted to the GI inpatient service with expected length of stay >24 hours
  • Prior diagnosis of a disorder of gut-brain interaction, esophageal disorder, or inflammatory bowel disease
  • Reason for hospitalization related to symptom management for exacerbation of visceral pain and/or nausea.

Exclusion criteria

Exclusion Criteria:

  • Currently using hypnosis
  • severe developmental delay or cognitive impairment
  • serious mental illness (i.e. psychosis or dissociation)
  • hearing impairment
  • Non-English speaking
  • enrolled in another trial for GI symptom management
  • admitted for GI procedure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    Hypnosis

    Participants will undergo gut-directed hypnotherapy via a phone intervention (10 minute recording, at least once daily while hospitalized) and for as much as participant would like for the 3 month duration of the study.

    Behavioral: Gut directed hypnotherapy via telephone intervention

  • Sham comparator
    Education

    Participants will listen to educational recording (10 minute recording, at least once daily while hospitalized) and for as much as participant would like for the 3 month duration of the study.

    Behavioral: Educational recording

Interventions

  • BehavioralGut directed hypnotherapy via telephone intervention

    Participants will undergo a self-directed gut-directed hypnosis intervention over the telephone.

  • BehavioralEducational recording

    Participants will listen to educational material over the telephone about their gastrointestinal symptoms.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Recruitment rate is the proportion enrolled among eligible patients approached.

    Time frame: Up to 1 year.

  2. Number of participants who adhered to intervention

    Proportion of participants completing ≥1 hypnosis session during hospitalization and total number of listens

    Time frame: 3 months.

  3. Retention rate

    Retention rate is defined as survey completion at baseline, 1 week, 1 month, and 3 months.

    Time frame: 3 months.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Jul 2027, 8 months after the start.

Of 285 non-industry interventional studies with no phase under Inflammatory Bowel Diseases, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 8 months is below that.

Counting every sponsor, half of 299 studies reached it within 26 months; a quarter within 14 and three quarters within 50.

Start moved once since we started tracking on Sep 25, 2026: Jul 2026 → Nov 2026, on Nov 18, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 23, 2026
First posted
Jun 30, 2026
StartActual
Nov 6, 2026was Jul 2026
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Stanford University is now Recruiting
Nov 18, 2026
Start date
Jul 2026→Nov 6, 2026 (actual)
Nov 18, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Stanford University · Stanford, United StatesContact added e•••@stanford.edu · •••4119Contact added (no phone or email listed)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Stanford University is now Recruiting
    Start date Jul 2026→Nov 6, 2026 (now actual)
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Stanford University · Stanford, United StatesContact added e•••@stanford.edu · •••4119Contact added (no phone or email listed)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07676136
Collaborators
American College of Gastroenterology
Responsible party
Irene Sonu (Clinical Associate Professor in Medicine, Stanford University) — Principal investigator
First posted
Jun 30, 2026
Start date
Nov 6, 2026
Primary completion
Jul 2027 (estimated)
Completion
Jul 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Irene Sonu, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion